OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
Mengmeng Lin, Yingying Li, Shiyuan Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 14

Showing 14 citing articles:

Lung cancer metabolomics: a pooled analysis in the Cancer Prevention Studies
Ziyin Tang, Donghai Liang, Emily L. Deubler, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11

DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes
Anwar A. Khan, Boreom Lee
Expert Systems with Applications (2023) Vol. 226, pp. 120047-120047
Open Access | Times Cited: 18

Machine Learning Unveils Sphingolipid Metabolism's Role in Tumour Microenvironment and Immunotherapy in Lung Cancer
Lili Xu, Jianchun Wu, Jianhui Tian, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access

Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study
Honglin Li, Lei Zhang, Feiran Yang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 7

Sphingolipid Metabolism in Tumor Cells
Vadim S. Pokrovsky, В. И. Иванова-Радкевич, Olga Kuznetsova
Biochemistry (Moscow) (2023) Vol. 88, Iss. 7, pp. 847-866
Closed Access | Times Cited: 5

Integrated bulk and single-cell profiling characterize sphingolipid metabolism in pancreatic cancer
Biao Zhang, Bolin Zhang, Tingxin Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Serum Metabolomics Study to Screen Potential Biomarkers of Lung Cancer Risk in High Natural Background Radiation Areas of Thailand: A Pilot Study
Narongchai Autsavapromporn, Aphidet Duangya, Pitchayaponne Klunklin, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4182-4182
Open Access | Times Cited: 1

The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents
Gabriel da Silva, Thaís Moré Milan, Andréia Machado Leopoldino
Gene (2023) Vol. 897, pp. 148063-148063
Closed Access | Times Cited: 2

The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy
V. E. Blokhin, Т. М. Заварыкина, Vasily Kotsuba, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2843-2843
Open Access

Five-hub genes identify potential mechanisms for the progression of asthma to lung cancer
Weichang Yang, Zhouhua Li, Wenjun Wang, et al.
Medicine (2023) Vol. 102, Iss. 6, pp. e32861-e32861
Open Access | Times Cited: 1

A Comprehensive Exploration of Metabolism and Tumor Microenvironment and Immunotherapy Response: Evidence From Large Populations in Non-small Cell Lung Cancer
Baorong Chen, Qinghua Hou, Linzhuang Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 1, pp. 46-58
Closed Access

Mechanism underlying the effect of MnO2 nanosheets for A549 cell chemodynamic therapy
Jian Liu, Changchun Wen, Miaomiao Hu, et al.
Microchimica Acta (2023) Vol. 190, Iss. 10
Closed Access

Metabolism of sphingolipids in tumor cells
Vadim S. Pokrovsky, В. И. Иванова-Радкевич, Olga Kuznetsova
Биохимия (2023) Vol. 88, Iss. 7, pp. 1045-1068
Closed Access

Page 1

Scroll to top